PUVA Therapy

This is a treatment for skin conditions like psoriasis. It uses a special medicine called psoralen, which makes the skin more sensitive to sunlight. Then, the patient gets a special type of sunlight (UVA) to help clear the skin.

Therapy

What people using PUVA Therapy report

Every report comes from a Lived member, sent anonymously.

Have you tried PUVA Therapy for Psoriasis?

NameHow it went

About PUVA Therapy

How It Works

PUVA (psoralen plus ultraviolet A) is a light treatment for skin disease that pairs a light-sensitizing medicine with carefully measured doses of ultraviolet A (UVA), the long-wave part of sunlight. The medicine, a psoralen, is usually methoxsalen, taken as a capsule before each session. Some clinics apply the psoralen to the skin instead, in a bath or a hand and foot soak. Neither part does much alone at these doses. The psoralen makes skin cells temporarily very sensitive to UVA, and when the light reaches them it binds to their DNA. That slows the overactive cell growth that builds the thick, scaly plaques of psoriasis and calms the immune cells driving the inflammation. In vitiligo, the same process can prompt pigment cells to return color to pale patches. The light sensitivity is also why treatment days come with strict precautions, and the effect on DNA is the reason PUVA carries a long-term skin cancer risk.

Who It's For

PUVA is mainly used for adults with severe psoriasis that has not responded well enough to other treatments. Oral methoxsalen with UVA is FDA approved for severe, disabling psoriasis that has resisted other therapy, once the diagnosis is confirmed by a skin biopsy, and it is given under the supervision of a dermatologist trained in light treatment. Dermatologists also use it for vitiligo, usually when narrowband UVB (a light treatment that needs no psoralen) has not worked; for early-stage mycosis fungoides, the most common lymphoma that starts in the skin; and, as a soak, for psoriasis or long-lasting eczema on the palms and soles. Because narrowband UVB is simpler and carries less cancer risk, PUVA is generally a second choice rather than a first one.

What It Involves

Before starting, the dermatologist confirms the diagnosis and reviews your skin cancer history, eye health and medicines. Your skin type, meaning how easily you burn or tan, sets the first light dose, and some clinics first test the smallest dose that turns your skin pink. For oral PUVA, you take the capsule 1.5 to 2 hours before the session with low-fat food or milk. You then stand in a cabinet lined with UVA lamps for a timed exposure, wearing UVA-blocking goggles, with sensitive areas shielded as needed (men's genitals are covered unless they are affected). Sessions are usually two or three times a week and never on back-to-back days, because a burn can take 48 hours to show. The dose rises gradually as your skin adjusts. After each oral dose your eyes and skin stay sensitive to sunlight. Wear wrap-around UVA-blocking sunglasses whenever it is daylight for the next 24 hours, indoors near windows as well as outside. Avoid the sun for at least 8 hours, even through window glass or cloud; if you cannot, cover up and use a UVA-protective sunscreen. Skip sunbathing the day before and for 48 hours after. Bath and soak PUVA put the psoralen only on the skin being treated, and the clinic will explain how its precautions differ.

What to Expect

Expect treatment to take weeks to months of regular visits. In psoriasis trials, people whose skin cleared needed about 17 sessions on average. Vitiligo is slower, and studies have run three sessions a week for 6 to 12 months. Mild pinkness a day or two after a session is expected and shows the treatment is reaching the skin. Unlike sunburn, PUVA redness can keep building and often peaks 48 hours or more after a dose, so the team adjusts the next dose based on how your skin looked in between. Your skin will tan. About 1 in 10 people have itching, which moisturizers usually help, and about 1 in 10 feel nauseated after the capsule; taking it with food or milk, or splitting the dose, can ease this. Response varies. In one trial, people with darker skin cleared less often than people with lighter skin. Once psoriasis clears, treatment is stopped or tapered, and symptoms usually return at some point, although clearance after PUVA tends to last longer than after narrowband UVB.

What the Evidence Says

For chronic plaque psoriasis, randomized trials show PUVA is highly effective. In a review of 29 trials, about 80% of people improved by at least three quarters. Compared directly with narrowband UVB, PUVA cleared skin in more people and in fewer sessions: in one double-blind trial, 84% versus 65% cleared, and six months later 68% of the PUVA group were still clear compared with 35%. Many of these trials are older and small, but the direction of the results is consistent. That advantage is weighed against cancer risk, which is why dermatologists usually try narrowband UVB first. For vitiligo the balance tips further: narrowband UVB has restored color better than PUVA in comparative studies and gives a more even color match. For early-stage mycosis fungoides, about 9 in 10 people respond to either treatment, and PUVA was linked to a longer time before the disease returned. A guideline review also supports soak PUVA for psoriasis and long-lasting eczema on the palms and soles.

Risks & Considerations

Skin cancer is the main long-term concern. In a large US follow-up study, the risk of squamous cell carcinoma rose steadily with the number of treatments, appeared even on skin not directly exposed such as the genitals, and continued after treatment stopped. The same study found melanoma more than doubled among people who had at least 200 treatments; European registry studies found a smaller increase in risk. Anyone who has had PUVA needs regular skin checks for life, and new, changing or non-healing spots should be shown to a dermatologist. Earlier arsenic treatment, radiation therapy, or heavy tar and UVB treatment adds to the risk. Too much drug or light, or sun after a dose, can cause a severe burn. Blistering, or redness that is painful or spreading, needs a prompt call to the treatment team before your next session. Without proper eye protection, psoralen and UVA can cause cataracts; with it, studies have not shown a clear increase. Over time PUVA also ages the skin prematurely. PUVA is not used in people with melanoma now or in the past, invasive squamous cell carcinoma, or an eye without its natural lens. Diseases that make skin sensitive to light, such as lupus or porphyria, usually rule it out too. Liver disease, heart disease that makes standing in a warm cabinet hard, and older age call for extra care. Whether methoxsalen harms a developing baby is unknown, so it is used in pregnancy, or by anyone who could become pregnant, only when clearly needed. Tell the team about other light-sensitizing medicines, such as tetracycline or fluoroquinolone antibiotics, sulfa drugs and thiazide water pills, and coal tar products. The practical cost is time: several clinic visits a week for months, plus eye and sun precautions on every treatment day. PUVA is used less often than it once was.

Questions to Ask Your Doctor

  1. 1.Why do you recommend PUVA rather than narrowband UVB or a medicine for my condition?
  2. 2.Would oral PUVA or a bath or soak version suit the areas I need treated?
  3. 3.How many sessions should I expect, and how will we judge whether it is working?
  4. 4.How will you track my total number of treatments, and how often should I have skin checks afterward?
  5. 5.Do any of my current medicines or health conditions make PUVA riskier for me?

Last reviewed • Oct 2026

Educational content, not medical advice.